Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on for cognitive symptoms in schizophrenia
IRCT20180301038906N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in schizophrenia comparing Memantine add-on with Placebo add-on (2 arms). Primary endpoints: Changes in psychotic symptoms, Changes in cognitive symptoms and 2 more. Started Apr 2015; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20180301038906N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180301038906N1.